Sumitomo Parkinson’s Filing A Pivotal Moment For Japan’s iPSC Ambitions

US Trial Also Ongoing

 
• By Lisa Takagi
  
Sumitomo's iPSC candidate for Parkinson's Disease
Sumitomo makes global-first approval filing for iPSC candidate for Parkinson's disease (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Japan